Immunologic analyses of peripheral leukocytes from workers at an ethical narcotics manufacturing facility.
Little information exists about possible adverse health effects associated with workplace exposure to opiate compounds. We have previously reported opiate-specific IgG antibodies, positive epicutaneous tests, and pulmonary function decrements in workers exposed occupationally to opiates. In the present work, we extended these findings to investigate the effect of occupational opiate exposure on lymphocyte subpopulations and mitogen-induced lymphoblastogenesis. Thirty-three opiate-exposed workers and 8 nonexposed control workers were evaluated for lymphocyte subpopulation absolute numbers and percentages, by evaluating cell surface antigen expression with flow cytometry. A complete blood count with differential, common clinical chemistry parameters, and serum immunoglobulin levels were also evaluated. Opiate-exposed workers showed significantly (p < .05) increased absolute numbers and percentages of HLA-DR+ cells (MHC class II histocompatibility antigen), significantly (p < .01) decreased percentages of T helper-inducer (CD4+) cells, and significantly (p < .05) decreased numbers of basophils, compared with nonexposed opiate workers from the same factory. A trend toward reduction in the T helper-inducer (CD4+)/T cytotoxic-suppressor (CD8+) lymphocyte ratio was also evident. There was also a significant decrease in lymphocyte activity stimulated by pokeweed mitogen (p < .05) in opiate-exposed workers. These data indicate that occupational opiate exposure may change the number and types of circulating peripheral blood leukocytes, or alternatively, alter the expression of receptors on the surface of these cells. In addition, occupational opiate exposure appears to decrease the sensitivity of B-cells to pokeweed mitogen stimulation.(ABSTRACT TRUNCATED AT 250 WORDS)
Biagini
R E
RE
Centers for Disease Control and Prevention, Division of Biomedical and Behavioral Science, Atlanta, Georgia, USA.
Henningsen
G M
GM
Klincewicz
S L
SL
D015703:Antigens, CD / Q000302:isolation & purification; D001249:Asthma / Q000139:chemically induced; D004345:Drug Industry; D004989:Ethics; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007962:Leukocytes / Q000276:immunology*; D008213:Lymphocyte Activation / Q000187:drug effects; D008297:Male; D008934:Mitogens; D009294:Narcotics / Q000009:adverse effects* / Q000276:immunology; D016273:Occupational Exposure; D010641:Phenotype
D015703:Antigens, CD; D008934:Mitogens; D009294:Narcotics